Publications

Publications

Filter Results: (2,659) Arrow Down
Filter Results: (2,659) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 33 of 2,659 Results →
  • 08 Nov 2012
  • Working Paper Summaries

Admitting Mistakes: Home Country Effect on the Reliability of Restatement Reporting

Keywords: by Suraj Srinivasan, Aida Sijamic Wahid & Gwen Yu
  • Program

Finance for Senior Executives

compensation incentives, and play a bigger role in helping your company optimize its financial resources and strengthen its bottom line. Details Apply strategic financial insight Make informed strategic decisions regarding capital... View Details
  • 01 Jan 2024
  • Blog Post

Answers to Your Top Questions about Financial Aid at HBS

something that is already on your mind. To help you get the information you need, we connected with the Financial Aid team to help answer the most frequently asked questions about financing an MBA. 1. What is HBS doing to make an MBA more... View Details
  • 2016
  • Book

Innovation Policy and the Economy, Volume 17

By: Shane Greenstein, Josh Lerner and Scott Stern
The seventeenth volume of the National Bureau of Economic Research’s Innovation Policy and the Economy provides an accessible forum for bringing the work of leading academic researchers to an audience of policymakers and those interested in the interaction... View Details
Keywords: Innovation and Invention; Technological Innovation; Governance; Policy; Economy
Related
  • July 2024
  • Case

Replika AI: Alleviating Loneliness (A)

By: Shikhar Ghosh and Shweta Bagai
Eugenia Kuyda launched Replika AI in 2017 as an empathetic digital companion to combat loneliness and provide emotional support. The platform surged in popularity during the COVID-19 pandemic, offering non-judgmental support to isolated users. By 2023, Replika boasted... View Details
Keywords: Entrepreneurship; Ethics; Health Pandemics; AI and Machine Learning; Well-being; Technology Industry
Related
  • Article

One Obstacle to Curing Cancer: Patient Data Isn't Shared

By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States
Related

    William A. Sahlman

    William Sahlman is a Baker Foundation Professor of Business Administration at Harvard Business School.

    Mr. Sahlman received an A.B. degree in Economics from Princeton University (1972), an M.B.A. from Harvard University (1975), and a Ph.D. in Business... View Details

    Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
    • Winter 2022
    • Article

    Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities

    By: Eric Budish, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast and Andrew A. Torkelson
    By January 2022, the COVAX international vaccine collaboration had allocated over a billion vaccines to over 140 countries. We describe and review the allocation process chosen, which reflected both an objective of equitably distributing vaccines across the world and... View Details
    Keywords: Vaccines; Pandemics; Health Care and Treatment; Health Pandemics; Distribution; Supply Chain; Equality and Inequality
    Related
    • Program

    Managing Turbulence

    impact in all three areas of strategic leadership. Immersed in a vibrant exchange with renowned HBS faculty and a global group of accomplished peers, you will share diverse perspectives and new industry insights. The opening and capstone... View Details
    • 2009
    • Working Paper

    Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings

    By: Joseph Rhatigan, Sachin H Jain, Joia S. Mukherjee and Michael E. Porter
    The care delivery value chain is a framework that can help conceptualize the organization and structure of care delivery for medical conditions.  We apply this framework to HIV/AIDS care in resource-limited settings. Several conclusions arise than can help inform... View Details
    Keywords: Customer Value and Value Chain; Framework; Health Care and Treatment; Health Disorders; Service Delivery
    Related
    • 2023
    • Working Paper

    The Market for Healthcare in Low Income Countries

    By: Abhijit Banerjee, Abhijit Chowdhury, Jishnu Das, Jeffrey Hammer, Reshmaan Hussam and Aakash Mohpal
    Patient trust is an important driver of the demand for healthcare. But it may also impact supply: doctors who realize that patients may not trust them may adjust their behavior in response. We assemble a large dataset that assesses clinical performance using... View Details
    Keywords: Health Care and Treatment; Quality; Developing Countries and Economies; Trust
    Related
    • October 2019 (Revised April 2020)
    • Background Note

    Note on Funding Deep Tech Startups

    By: Karim Lakhani, Peter Barrett and Noubar Afeyan
    This Background Note provides essential information on funding deep technologies—those technologies that were inherently capital intensive, time consuming, risky, and potentially disruptive. Both dilutive and non-dilutive sources of investment are highlighted, along... View Details
    Keywords: Entrepreneurship; Energy; Venture Capital; Corporate Finance; Initial Public Offering; Investment; Health Testing and Trials; Innovation and Invention; Technological Innovation; Intellectual Property; Product Design; Product Development; Information Technology; Research and Development; Risk and Uncertainty; Technology Industry; Biotechnology Industry; United States; North America; Europe; Asia
    Related
    • December 2021 (Revised May 2022)
    • Case

    Troverie (A)

    By: Thomas R. Eisenmann, Lindsay N. Hyde and Olivia Graham
    Six months after the August 2018 launch of Troverie, a U.S.-based online retailer of luxury watches, the average cost of acquiring a customer is much higher than originally projected, and the startup is incurring a substantial loss on each sales transaction. Could... View Details
    Keywords: Startup; Luxury Goods; Customer Acquisition; Entrepreneurship; Business Startups; Luxury; Failure; Internet and the Web; Revenue; Fashion Industry; United States
    Related

      Richard F. Meyer

      Richard F. Meyer is Professor of Business Administration at the Harvard Business School. Professor Meyer received his Ph.D. from Harvard University and spent the first ten years of his career in the Management Services Division of Arthur D. Little, Inc., serving as a... View Details
      • 02 Mar 2023
      • Blog Post

      Women, Work, and the "M" Word

      information and access evidence-based information related to their physical and emotional health and well-being. Employee resource groups or affinity groups can be a powerful... View Details
      • Web

      Faculty & Advisors | MBA

      Faculty & Advisors MS/MBA Biotechnology: Life Sciences Faculty Amitabh Chandra, Ph.D. Henry and Allison McCance Professor of Business Administration at HBS, Ethel Zimmerman Winer Professor of Public Policy and Director of Health Policy... View Details
      • September 2019
      • Article

      The Effect of Enforcement Transparency: Evidence from SEC Comment-Letter Reviews

      By: Miguel Duro, Jonas Heese and Gaizka Ormazabal
      This paper studies the effect of the public disclosure of the Securities and Exchange Commission (SEC) comment-letter reviews (CLs) on firms’ financial reporting. We exploit a major change in the SEC’s disclosure policy: in 2004, the SEC decided to make its CLs... View Details
      Keywords: Disclosure; SEC Comment-Letter Reviews; Public Enforcement; Governance; Information Publishing; Policy; Financial Reporting; Capital Markets; Organizational Change and Adaptation
      Related
      • Program

      Women on Boards

      Summary Traditionally, the majority of board appointments are made through informal networks that are especially hard for women to break into. Designed specifically for top women executives, this program provides insight into navigating... View Details
      • May 2014
      • Article

      Incorporating Field Data into Archival Research

      By: Eugene F. Soltes
      I explore the use of field data in conjunction with archival evidence by examining Iliev, Miller, and Roth's (2014) analysis of an amendment to the Securities Exchange Act of 1934. This regulatory amendment allowed depositary banks to cross-list firms without the... View Details
      Keywords: Analytics and Data Science; Research; Financial Reporting
      Related
      • 16 Aug 2024
      • In Practice

      Election 2024: What's at Stake for Business and the Workplace?

      volunteer as poll workers. Facilitate political engagement. Look to online platforms that have simplified small contributions to political campaigns and increased the diversity of donors, as well as efforts to encourage employees and customers to run for office by... View Details
      Keywords: by Rachel Layne